BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20610494)

  • 1. Correlation of self-assessed fatigue and alertness in multiple sclerosis.
    Weinges-Evers N; Brandt AU; Bock M; Pfueller CF; Dörr J; Bellmann-Strobl J; Scherer P; Urbanek C; Boers C; Ohlraun S; Zipp F; Paul F
    Mult Scler; 2010 Sep; 16(9):1134-40. PubMed ID: 20610494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment.
    Flachenecker P; Meissner H
    Mult Scler; 2008 Mar; 14(2):274-7. PubMed ID: 18337428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome.
    Khalil M; Enzinger C; Langkammer C; Petrovic K; Loitfelder M; Tscherner M; Jehna M; Bachmaier G; Wallner-Blazek M; Ropele S; Schmidt R; Fuchs S; Fazekas F
    Mult Scler; 2011 Feb; 17(2):173-80. PubMed ID: 20956399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standards for sample composition and impairment classification in neuropsychological studies of multiple sclerosis.
    Benedict R
    Mult Scler; 2009 Jul; 15(7):777-8. PubMed ID: 19542261
    [No Abstract]   [Full Text] [Related]  

  • 7. Symptom cluster and physical activity in relapsing-remitting multiple sclerosis.
    Motl RW; Weikert M; Suh Y; Dlugonski D
    Res Nurs Health; 2010 Oct; 33(5):398-412. PubMed ID: 20725947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms and physical activity among adults with relapsing-remitting multiple sclerosis.
    Motl RW; McAuley E; Wynn D; Suh Y; Weikert M; Dlugonski D
    J Nerv Ment Dis; 2010 Mar; 198(3):213-9. PubMed ID: 20215999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis.
    Morrow SA; Weinstock-Guttman B; Munschauer FE; Hojnacki D; Benedict RH
    Mult Scler; 2009 Aug; 15(8):998-1005. PubMed ID: 19667024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue, mood and quality of life improve in MS patients after progressive resistance training.
    Dalgas U; Stenager E; Jakobsen J; Petersen T; Hansen HJ; Knudsen C; Overgaard K; Ingemann-Hansen T
    Mult Scler; 2010 Apr; 16(4):480-90. PubMed ID: 20194584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study.
    Mendozzi L; Tronci F; Garegnani M; Pugnetti L
    Mult Scler; 2010 Feb; 16(2):238-47. PubMed ID: 20028705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatigue and social impairment in multiple sclerosis: the role of patients' cognitive and behavioral responses to their symptoms.
    Skerrett TN; Moss-Morris R
    J Psychosom Res; 2006 Nov; 61(5):587-93. PubMed ID: 17084135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression in multiple sclerosis: combining physicians' and patients' perspectives?
    Kragt JJ; Nielsen JM; van der Linden FA; Polman CH; Uitdehaag BM
    Mult Scler; 2011 Feb; 17(2):234-40. PubMed ID: 20978037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue.
    Penner IK; Raselli C; Stöcklin M; Opwis K; Kappos L; Calabrese P
    Mult Scler; 2009 Dec; 15(12):1509-17. PubMed ID: 19995840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Audio Recorded Cognitive Screen (ARCS) in patients with multiple sclerosis: a practical tool for multiple sclerosis clinics.
    Lechner-Scott J; Kerr T; Spencer B; Agland S; Lydon A; Schofield PW
    Mult Scler; 2010 Sep; 16(9):1126-33. PubMed ID: 20621944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment in multiple sclerosis: a longitudinal study.
    Amato MP; Ponziani G; Amaducci L
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():465-8. PubMed ID: 10689495
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatigued patients with multiple sclerosis have impaired central muscle activation.
    Andreasen AK; Jakobsen J; Petersen T; Andersen H
    Mult Scler; 2009 Jul; 15(7):818-27. PubMed ID: 19465444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom clusters in women with relapsing-remitting multiple sclerosis.
    Newland PK; Fearing A; Riley M; Neath A
    J Neurosci Nurs; 2012 Apr; 44(2):66-71. PubMed ID: 22367268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating functional decline in patients with Multiple Sclerosis.
    Rosenblum S; Tamar Weiss PL
    Res Dev Disabil; 2010; 31(2):577-86. PubMed ID: 20047816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.